Integrative clinical and molecular characterization of translocation renal cell carcinoma

Bakouny et al. perform integrative genomic analyses of MiT/TFE-translocation renal cell carcinoma (tRCC) to define the hallmarks of this rare form of kidney cancer. They find that tRCC harbors few recurrent genomic alterations, is characterized by NRF2 activation, and is resistant to targeted therapies but may show responses to immunotherapy.

Read the full article here

Related Articles